Study to Evaluate CCS1477 in Haematological Malignancies

This is an early phase study, looking to find out more about a new type of targeted treatment called CCS1477.
This drug targets proteins called histone acetyltransferases (HATs), which control the way some cells develop. The drug stops HATs working, which stops cancer cells from growing. As this is in the early phase, not much is known about how the drug will work and therefore it may not benefit some trial participants.
However, any results will inform future studies and trials, helping people with WM in the future.